Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson expect to incur $100M charge to net income in Q1
Johnson & Johnson expect to incur $100M charge to net income in Q1
Johnson & Johnson expect to incur $100M charge to net income in Q1
Submitted by
admin
on February 25, 2013 - 9:48am
Source:
The Fly on the Wall
News Tags:
JNJ
guidance
Headline:
Johnson & Johnson expect to incur $100M charge to net income in Q1
Do Not Allow Advertisers to Use My Personal information
